Purple Biotech (Purple Biotech) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Purple Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Purple Biotech's Free Cash Flow for the three months ended in Dec. 2023 was $-4.98 Mil. Purple Biotech's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, Purple Biotech's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Purple Biotech's current FCF Yield % is -135.28%.

The historical rank and industry rank for Purple Biotech's FCF Margin % or its related term are showing as below:

During the past 11 years, the highest FCF Margin % of Purple Biotech was -849.57%. The lowest was -8639.73%. And the median was -4744.65%.

PPBT's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -148.935
* Ranked among companies with meaningful FCF Margin % only.

Purple Biotech FCF Margin % Historical Data

The historical data trend for Purple Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech FCF Margin % Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

Purple Biotech Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Purple Biotech's FCF Margin %

For the Biotechnology subindustry, Purple Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Purple Biotech's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Purple Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Purple Biotech's FCF Margin % falls into.

Purple Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Purple Biotech's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-19.928	/	0
	=	%

Purple Biotech's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-4.982	/	0
	=	%

Purple Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Purple Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (Purple Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (NAS:PPBT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

PPBT:Israel 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.